Work

Regorafenib as second-line therapy in hepatocellular carcinoma

Year: 2017

Type: article

Source: Nature Reviews Gastroenterology & Hepatology

DOI: 10.1038/nrgastro.2017.7

Authors: Austin G. Duffy, Tim F. Greten

Institutions: National Cancer Institute, Center for Cancer Research

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586907906

FWCI: 2.634

Cites: 11

Cited by: 34

Related to: 10